Literature DB >> 8982382

A comparative immunohistochemical study of mammary and extramammary Paget's disease and superficial spreading melanoma, with particular emphasis on melanocytic markers.

S Ramachandra1, C E Gillett, R R Millis.   

Abstract

A comparative immunohistochemical study was performed on Paget's disease of the nipple (PDN), extramammary Paget's disease (EMPD) and cutaneous superficial spreading melanoma (SSM) using antibodies to S100, NK1-C3 and HMB45, cytokeratin (CAM 5.2) and c-erb B2 oncoprotein (21N). Conventional histochemical stains for intracytoplasmic mucin and melanin were also done. Of the 20 cases of PDN, positivity was seen in 12 with S100, 16 with NK1-C3, none with HMB45, 20 with CAM 5.2 and 19 with 21N. All 5 cases of EMPD were CAM 5.2 positive and HMB45, S100 and 21N negative. Three EMPD were NK1-C3 positive. All 10 cases of SSM were S100, NK1-C3 and HMB45 positive and all were CAM5.2 and 21N negative. Mucin was demonstrable in 11 cases of PDN and all of EMPD but none of SSM. Melanin was seen in 2 PDN, 3 EMPD and all SSM cases. Identification of mucin and melanin, therefore, proved an unreliable means of distinguishing these diseases. Immunohistochemistry for cytokeratin and HMB45 appear to be the most specific markers in differentiating Paget's disease and SSM. Antibodies to c-erb B2 may also be valuable in this situation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8982382     DOI: 10.1007/bf00198442

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  3 in total

1.  Immunohistochemical determination of HER-2/neu, c-Kit (CD117), and vascular endothelial growth factor (VEGF) overexpression in malignant melanoma.

Authors:  Anil Potti; Nauman Moazzam; Eric Langness; Kaley Sholes; Ketki Tendulkar; Michael Koch; Steve Kargas
Journal:  J Cancer Res Clin Oncol       Date:  2003-11-21       Impact factor: 4.553

2.  Mammary Paget Disease With Melanocytic Proliferation Mimicking Malignant Melanoma in situ: A Case Report.

Authors:  Shijia Rao; Alun Wang; Wei Liu; Hongling Yin; Ji Li; Lemuel Shui-Lun Tsang; Yuhui Wu; Wei Shi
Journal:  Front Med (Lausanne)       Date:  2022-03-21

3.  Immunohistochemical determination of HER-2/neu overexpression in malignant melanoma reveals no prognostic value, while c-Kit (CD117) overexpression exhibits potential therapeutic implications.

Authors:  Anil Potti; Rachel C Hille; Michael Koch
Journal:  J Carcinog       Date:  2003-11-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.